Jänne, P. A., Theelen, W. S., Garassino, M. C., Spira, A. I., Laskin, J. J., Marinis, F. D., Badin, F. B., Boom, L., Rosa, C. A. D. L., Chmielewska, I., Felip, E., Ostoros, G., Jimenez-Kurlander, L., Lane, C. M., Sachdeva, A., Eccles, L., Lu, S. (2025). First-line adagrasib (ADA) with pembrolizumab (PEMBRO) in patients (pts) with advanced/metastatic KRAS G12C -mutated non-small cell lung cancer (NSCLC) from the phase 2 portion of the KRYSTAL-7 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8500